Literature DB >> 21190093

Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis.

Nishant Poddar1, Boris Avezbakiyev, Zili He, Ming Jiang, Arash Gohari, Jen Chen Wang.   

Abstract

INTRODUCTION: Portal vein thrombosis is frequently associated with hepatocellular carcinoma (HCC). Tumor invasion into the portal vein by direct venous extension or metastasis occurs in up to 70% of HCC patients (Cedrone et al., Liver 16:94-8, 1996). However, presentation as an isolated malignant portal vein thrombosis without any evidence of obvious hepatoma-like lesions in the liver by imaging studies is extremely uncommon. We present an unusual case of HCC presenting as a malignant portal vein thrombus, proven on biopsy of the thrombus without any evidence of primary liver lesion. This, to our knowledge, is the first case of HCC presenting as an incidental isolated malignant portal vein thrombosis. The importance of doing delayed enhancement imaging studies to rule out malignant portal vein thrombosis is emphasized. CASE REPORT: A 60-year-old man presented with acute substernal chest pain. Physical examination revealed icterus. Examination of the abdomen did not reveal any organomegaly. Liver function test revealed a predominantly conjugated bilirubinemia. Abdominal sonogram revealed thrombosis and occlusion of the posterior right portal vein. Liver parenchyma was homogenous with no intrahepatic mass. Computed tomography (CT) of the abdomen and pelvis after administration of oral and intravenous contrast with delayed views revealed arterial enhancement of the right portal vein thrombus with delayed washout. MRI of the abdomen with gadolinium confirmed the right portal vein thrombus without focal hepatic mass. Aspiration of the right portal vein thrombus under CT guidance revealed hepatocellular carcinoma which was confirmed by immunohistochemistry. Serum alpha-fetoprotein level was very high. Patient was started on sorafenib with subsequent decrease in alpha-fetoprotein level. He was doing well till the date of this report. DISCUSSION: This unusual case of hepatocellular carcinoma presenting as an incidental malignant portal vein thrombosis without any primary liver lesion is extremely rare. Other reported cases of malignant portal vein thrombosis have been in patients with underlying hepatoma, cirrhosis, or with intrabiliary hepatocelluar carcinoma. In the clinical setting of portal vein thrombosis, imaging studies showing enhancement of the thrombus in the arterial phase are important in leading to the diagnosis of malignancy.

Entities:  

Mesh:

Year:  2012        PMID: 21190093     DOI: 10.1007/s12029-010-9235-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  18 in total

1.  Diagnosis and staging of hepatocellular carcinoma by EUS-FNA of a portal vein thrombus.

Authors:  Rebecca Lai; Valerie Stephens; Ricardo Bardales
Journal:  Gastrointest Endosc       Date:  2004-04       Impact factor: 9.427

2.  Hepatocellular carcinoma presenting as portal thrombosis with intrabiliary growth: US and MR findings.

Authors:  M J Diaz-Ruiz; J Falcó; J Martin; R M Bella; M Carrasco; L Tortajada
Journal:  Abdom Imaging       Date:  2000 May-Jun

3.  Hepatocellular carcinoma.

Authors:  A M Di Bisceglie; R L Carithers; G J Gores
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

4.  Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.

Authors:  J Bruix; J M Barrera; X Calvet; G Ercilla; J Costa; J M Sanchez-Tapias; M Ventura; M Vall; M Bruguera; C Bru
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

5.  Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

Authors:  M Chiaramonte; T Stroffolini; A Vian; M A Stazi; A Floreani; U Lorenzoni; S Lobello; F Farinati; R Naccarato
Journal:  Cancer       Date:  1999-05-15       Impact factor: 6.860

6.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease.

Authors:  H Tsukuma; T Hiyama; S Tanaka; M Nakao; T Yabuuchi; T Kitamura; K Nakanishi; I Fujimoto; A Inoue; H Yamazaki
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

7.  A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.

Authors:  K Ikeda; S Saitoh; I Koida; Y Arase; A Tsubota; K Chayama; H Kumada; M Kawanishi
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

8.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Authors:  Sean F Altekruse; Katherine A McGlynn; Marsha E Reichman
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

9.  Ultrasonically guided fine-needle aspiration biopsy of portal vein thrombosis: a cytomorphological study of 14 patients.

Authors:  M O Adeyanju; G D Dodd; J R Madariaga; A Dekker
Journal:  Diagn Cytopathol       Date:  1994       Impact factor: 1.582

10.  MRI in detection of hepatocellular carcinoma (HCC).

Authors:  Subba R Digumarthy; Dushyant V Sahani; Sanjay Saini
Journal:  Cancer Imaging       Date:  2005-04-13       Impact factor: 3.909

View more
  9 in total

1.  Isolated Portal Venous Hepatocellular Carcinoma.

Authors:  John Mutai; Twahirwa Nebayosi; Joyce Sande; M V Shah
Journal:  J Gastrointest Cancer       Date:  2017-03

2.  EUS-FNA of portal venous tumoral thrombosis for diagnosis of hepatocellular carcinoma without primary hepatic mass (with video).

Authors:  Ludivine Gan; Fanny Houser; Thomas Di Bernardo; Aude Le Goffic; Philippe Ah-Soune
Journal:  Endosc Ultrasound       Date:  2021 Jan-Feb       Impact factor: 5.628

3.  Liver metastasis from hepatoid adenocarcinoma of the stomach mimicking hepatocellular carcinoma: Dynamic computed tomography findings.

Authors:  Yang-Yu Lin; Chien-Ming Chen; Yu-Hsiu Huang; Cheng-Yu Lin; Sung-Yu Chu; Ming-Yi Hsu; Kuang-Tse Pan; Jeng-Hwei Tseng
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

4.  Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus.

Authors:  Jun-Hui Sun; Tanyang Zhou; Tongyin Zhu; Yuelin Zhang; Chunhui Nie; Jing Ai; Guanhui Zhou; Aibin Zhang; Meng-Jie Dong; Wei-Lin Wang; Shu-Sen Zheng
Journal:  Biomed Res Int       Date:  2016-11-24       Impact factor: 3.411

5.  Y-configuration stent combined with iodine-125 seeds strand for the treatment of hepatocellular carcinoma with tumor thrombosis in portal vein branches: A case report.

Authors:  Tan Tan; Yudong Xiao; Shunke Zhou; Cong Ma; Zishu Zhang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

6.  Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature.

Authors:  Anıl Çolaklar; Namık Kemal Altınbaş
Journal:  J Ultrason       Date:  2020-03-31

7.  Diagnosis of portal vein tumor thrombosis in colorectal carcinoma in fluorodeoxyglucose positron emission tomography-computed tomography scan and its clinical implication.

Authors:  Digish Shah
Journal:  World J Nucl Med       Date:  2020-07-22

8.  Metastatic Infiltration of Anaplastic Carcinoma of the Pancreas Into the Portal Venous System: A Masquerading Cause of Expansive Portal Venous Thrombosis.

Authors:  Yuka Hirakawa; Masaki Tago; Naoko E Katsuki; Seijiro Makio; Shu-Ichi Yamashita
Journal:  Am J Case Rep       Date:  2021-03-26

9.  A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China.

Authors:  Xiaowei Chi; Liejun Jiang; Yulin Yuan; Xinyan Huang; Xuemei Yang; Steven Hochwald; Jie Liu; Huayi Huang
Journal:  BMC Gastroenterol       Date:  2022-04-23       Impact factor: 2.847

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.